Spyre Therapeutics (SYRE) Shares Outstanding (2016 - 2024)
Historic Shares Outstanding for Spyre Therapeutics (SYRE) over the last 10 years, with Q3 2024 value amounting to $51.4 million.
- Spyre Therapeutics' Shares Outstanding rose 116935.05% to $51.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $51.4 million, marking a year-over-year increase of 116935.05%. This contributed to the annual value of $36.1 million for FY2023, which is 127938.03% up from last year.
- Latest data reveals that Spyre Therapeutics reported Shares Outstanding of $51.4 million as of Q3 2024, which was up 116935.05% from $50.8 million recorded in Q2 2024.
- Spyre Therapeutics' 5-year Shares Outstanding high stood at $51.4 million for Q3 2024, and its period low was $2.0 million during Q4 2021.
- Its 5-year average for Shares Outstanding is $26.8 million, with a median of $36.1 million in 2023.
- Per our database at Business Quant, Spyre Therapeutics' Shares Outstanding crashed by 9596.7% in 2022 and then skyrocketed by 146737.65% in 2024.
- Quarter analysis of 5 years shows Spyre Therapeutics' Shares Outstanding stood at $48.0 million in 2020, then plummeted by 95.88% to $2.0 million in 2021, then surged by 32.42% to $2.6 million in 2022, then surged by 1279.38% to $36.1 million in 2023, then skyrocketed by 42.54% to $51.4 million in 2024.
- Its Shares Outstanding was $51.4 million in Q3 2024, compared to $50.8 million in Q2 2024 and $36.6 million in Q1 2024.